Health Care & Life Sciences » Pharmaceuticals | WooGene B&G Co. Ltd.

WooGene B&G Co. Ltd.

WooGene B&G Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW358.67
Market Cap
KRW71.35 B
Shares Outstanding
16.22 M
Public Float
10.28 M

Profile

Address
230 Jeongmunsongsan-ro
Hwaseong GY 18629
Korea, Republic Of
Employees -
Website http://www.woogenebng.com
Updated 09/14/2018
WooGene B&G Co., Ltd. manufactures and sells veterinary pharmaceutical and nutraceutical products. It operates through the following divisions: Pharmaceuticals and Nutraceuticals. The Pharmaceutical division's products include anti-infective drugs, probiotics, anti-parasitics, hormone preparations, vaccines, anesthetics, teat dips, disinfectants, pet cure drugs, calcium injections, sedative injections, toxin binders and bacterial disease remedies.

Financials

View All
Created with Highcharts 5.0.14WooGene B&G Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.6066068218213533531751754 1904 1902013201420152016201701k2k3k4k5k
Created with Highcharts 5.0.14WooGene B&G Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.20 54620 54622 08722 08723 50723 50727 81927 81926 43426 4342013201420152016201705k10k15k20k25k30k

Seok-Jin Kang
Co-Chief Executive Officer & Director
Jae-Goo Kang
Co-Chief Executive Officer & Director